Overview

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Status:
Not yet recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
To evaluate the phase I/II clinical study of LBL-024 in the treatment of patients with advanced malignant tumors
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Nanjing Leads Biolabs Co.,Ltd